Literature DB >> 18674718

Cardiovascular risk, obesity, and myocardial blood flow in postmenopausal women.

Apurva A Motivala1, Patricia A Rose, H Myra Kim, Yolanda R Smith, Catherine Bartnik, Robert D Brook, Otto Muzik, Claire S Duvernoy.   

Abstract

BACKGROUND: This study was designed to determine whether overweight or obese status is independently associated with myocardial flow reserve (MFR), an established predictor of cardiovascular mortality, in a group of postmenopausal women with no previous cardiovascular disease. Postmenopausal women are the largest group of overweight and physically inactive individuals in the United States. Increased body mass index (BMI) is consistently associated with increased cardiovascular mortality in this population. Whether this is because of obesity itself or the accompanying increase in cardiovascular risk factors (CRFs) remains controversial.
METHODS: We examined the relationship of myocardial blood flow (MBF), coronary vascular resistance, and MFR to BMI in 60 postmenopausal women with no coronary heart disease. Subjects underwent dynamic N-13 ammonia positron emission tomography for the measurement of MBF and MFR. Baseline demographics, CRF, and hemodynamic parameters were recorded for each subject. Datasets were divided into 3 groups according to BMI: normal (18 to 24), overweight (25 to 29), and obese (>or=30).
RESULTS: The overweight and obese groups showed significantly higher resting MBF and lower MFR than the normal-weight group (both P < .001), even after adjusting for CRF. A further analysis of subjects without any CRF (n = 35) showed that the MFR remained significantly lower in the obese compared with normal-weight subjects (P = .05). Levels of known markers of vascular inflammation (high-sensitivity C-reactive protein and homocysteine) and high-density lipoprotein cholesterol levels correlated with declining MFR.
CONCLUSIONS: These findings provide a mechanistic link between obesity and coronary heart disease in this population.

Entities:  

Mesh:

Year:  2008        PMID: 18674718     DOI: 10.1016/j.nuclcard.2008.02.020

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  31 in total

Review 1.  Body fat distribution, the menopause transition, and hormone replacement therapy.

Authors:  A Tchernof; E T Poehlman; J P Després
Journal:  Diabetes Metab       Date:  2000-02       Impact factor: 6.041

2.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.

Authors:  J A Suwaidi; S Hamasaki; S T Higano; R A Nishimura; D R Holmes; A Lerman
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

3.  Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging.

Authors:  G D Hutchins; M Schwaiger; K C Rosenspire; J Krivokapich; H Schelbert; D E Kuhl
Journal:  J Am Coll Cardiol       Date:  1990-04       Impact factor: 24.094

4.  The epidemiology of resting heart rate in a national sample of men and women: associations with hypertension, coronary heart disease, blood pressure, and other cardiovascular risk factors.

Authors:  R F Gillum
Journal:  Am Heart J       Date:  1988-07       Impact factor: 4.749

5.  Gender difference in the effect of body composition on energy metabolism.

Authors:  I Dionne; J P Després; C Bouchard; A Tremblay
Journal:  Int J Obes Relat Metab Disord       Date:  1999-03

6.  Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries.

Authors:  J Al Suwaidi; S T Higano; D R Holmes; R Lennon; A Lerman
Journal:  J Am Coll Cardiol       Date:  2001-05       Impact factor: 24.094

Review 7.  Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase.

Authors:  Thomas Münzel; Andreas Daiber; Volker Ullrich; Alexander Mülsch
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-05-05       Impact factor: 8.311

8.  Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.

Authors:  H O Steinberg; H Chaker; R Leaming; A Johnson; G Brechtel; A D Baron
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

9.  Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Gregory O von Mering; Christopher B Arant; Timothy R Wessel; Susan P McGorray; C Noel Bairey Merz; Barry L Sharaf; Karen M Smith; Marian B Olson; B Delia Johnson; George Sopko; Eileen Handberg; Carl J Pepine; Richard A Kerensky
Journal:  Circulation       Date:  2004-02-17       Impact factor: 29.690

Review 10.  From big fat cells to high blood pressure: a pathway to obesity-associated hypertension.

Authors:  Zdenka Pausova
Journal:  Curr Opin Nephrol Hypertens       Date:  2006-03       Impact factor: 2.894

View more
  14 in total

1.  Are people with normal radionuclide perfusion imaging studies better-off if they are obese?

Authors:  Farbod Raiszadeh; Mark I Travin
Journal:  J Nucl Cardiol       Date:  2010-06       Impact factor: 5.952

2.  Myocardial blood flow: Putting it into clinical perspective.

Authors:  Thomas Hellmut Schindler
Journal:  J Nucl Cardiol       Date:  2015-12-28       Impact factor: 5.952

3.  Detecting the impact of emerging cardiovascular risk factors: the role of positron emission tomography.

Authors:  Danilo Neglia; Oberdan Parodi
Journal:  J Nucl Cardiol       Date:  2008 Jul-Aug       Impact factor: 5.952

Review 4.  Quantification of PET Myocardial Blood Flow.

Authors:  Matthieu Pelletier-Galarneau; Patrick Martineau; Georges El Fakhri
Journal:  Curr Cardiol Rep       Date:  2019-02-28       Impact factor: 2.931

Review 5.  Obesity and coronary microvascular disease - implications for adipose tissue-mediated remote inflammatory response.

Authors:  Zsolt Bagi; Zuzana Broskova; Attila Feher
Journal:  Curr Vasc Pharmacol       Date:  2014-05       Impact factor: 2.719

6.  Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients.

Authors:  Navkaranbir S Bajaj; Michael T Osborne; Ankur Gupta; Ali Tavakkoli; Paco E Bravo; Tomas Vita; Courtney F Bibbo; Jon Hainer; Sharmila Dorbala; Ron Blankstein; Deepak L Bhatt; Marcelo F Di Carli; Viviany R Taqueti
Journal:  J Am Coll Cardiol       Date:  2018-08-14       Impact factor: 24.094

Review 7.  The influence of insulin resistance, obesity, and diabetes mellitus on vascular tone and myocardial blood flow.

Authors:  Ines Valenta; Vasken Dilsizian; Alessandra Quercioli; Heinrich R Schelbert; Thomas H Schindler
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

8.  Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC.

Authors:  Venkatesh L Murthy; Timothy M Bateman; Rob S Beanlands; Daniel S Berman; Salvador Borges-Neto; Panithaya Chareonthaitawee; Manuel D Cerqueira; Robert A deKemp; E Gordon DePuey; Vasken Dilsizian; Sharmila Dorbala; Edward P Ficaro; Ernest V Garcia; Henry Gewirtz; Gary V Heller; Howard C Lewin; Saurabh Malhotra; April Mann; Terrence D Ruddy; Thomas H Schindler; Ronald G Schwartz; Piotr J Slomka; Prem Soman; Marcelo F Di Carli; Andrew Einstein; Raymond Russell; James R Corbett
Journal:  J Nucl Cardiol       Date:  2018-02       Impact factor: 5.952

Review 9.  Microvascular responsiveness in obesity: implications for therapeutic intervention.

Authors:  Zsolt Bagi; Attila Feher; James Cassuto
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

10.  Matching between regional coronary vasodilator capacity and corresponding circumferential strain in individuals with normal and increasing body weight.

Authors:  Gabriella M Vincenti; Giuseppe Ambrosio; Jean-Noël Hyacinthe; Alessandra Quercioli; Yann Seimbille; François Mach; Osman Ratib; Jean-Paul Vallée; Thomas H Schindler
Journal:  J Nucl Cardiol       Date:  2012-04-28       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.